Practical Neurology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Practical Neurology 2006;6:78-89; doi:10.1136/jnnp.2006.088757
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Corey-Bloom, J.
Right arrow Articles by Weisman, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Corey-Bloom, J.
Right arrow Articles by Weisman, D.

Reviews

Managing patients with Alzheimer’s disease

Jody Corey-Bloom, Roy Yaari, Dave Weisman

Department of Neurosciences, University of California, San Diego, San Diego Veteran’s Affairs Medical Center, La Jolla, CA, USA

Correspondence to:
Correspondence to:
J Corey-Bloom, MD, PhD, Neurology Service (9127), San Diego VA Medical Center, 3350 La Jolla Village Drive, San Diego, CA 92161-3064, USA;
jcoreybl@vapop.ucsd.edu

The first 150 words of the full text of this article appear below.


Figure 1

Alzheimer’s disease is a degenerative brain disorder characterised by progressive dementia that culminates in death. It affects 3% of those over the age of 65 and up to 50% over the age of 85, resulting in a cost of over $100 billion a year in the USA.1 Due to the ageing population, the societal burden of this disease is expected to increase over the next 40 years.2 The hallmark of Alzheimer’s disease is the insidious onset of memory loss, although one or more additional areas of cognitive impairment are usually evident on examination. Slow but relentless progression leads to worsening cognitive and behavioural problems, as the result of widespread areas of cortical dysfunction. Effective management consists of both pharmacological and non-pharmacological interventions to improve the quality of life of patients—and their carers.

PHARMACOLOGICAL TREATMENT

Current pharmacological treatments include both disease specific compounds as well as adjunctive therapies for the behavioural symptoms of . . . [Full text of this article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.